Project Number 1R56AG060631-01A1 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Identification and Development of Tau-Lowering Small-Molecule Drugs Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator MUCKE, LENNART Principal Investigator First Name LENNART Principal Investigator Last Name MUCKE Awardee Organization J. DAVID GLADSTONE INSTITUTES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-041: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R01) FY Overall Cost $1,703,867 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
